Benjamin Machinas Beneski serves as Executive at Allogene Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Benjamin Machinas Beneski has executed 1 insider transactions totaling $959, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 17, 2025 involved selling 786 shares valued at $959.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | ALLO | $959 | Sale | 786 | $1.22 | Discretionary |
Benjamin Machinas Beneski currently holds 217,721 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin Machinas Beneski has been a net seller of ALLO stock. They have purchased $0 and sold $959 worth of shares.
Benjamin Machinas Beneski's most recent insider trade was on Nov 17, 2025, when they sold 786 shares at $1.22 per share.
Get notified when new Form 4 filings are submitted